Indefinite Delivery Contract SPE2DR25D1992

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The federal contract IDV award SPE2DR25D1022 is a single-award Indefinite Delivery Contract issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain. The contract, valued at $999,999,999, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract, which runs through December...
The federal contract IDV award SPE2DR25D1931 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, has an ultimate completion date of December 31, 2036 and provides worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The contract aims to establish...
The federal contract IDV award SPE2DR25D6029 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp. The $999,999,999 contract, which runs through December 2036, covers the provision of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
The federal contract IDV award SPE2DR25D2228 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $999,999,999 and runs through December 2036, providing a broad range of pharmaceutical products and medical supplies to support various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies...
The federal contract IDV award SPE2DR25D6038 is a single-award, unrestricted Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by Amerisourcebergen Drug Corp. It was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency (DHA), the U.S. Coast Guard, and the U.S. Naval Fleet. The contract covers a broad range of...
The federal contract IDV award SPE2DR25D2911 is a single-award Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) Troop Support Medical and Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $999,999,999 and a performance period through December 2036. The contract aims to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) that will provide worldwide pharmaceutical support, including brand-name,...
The federal contract IDV award SPE2DR25D2006 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a 30-month base period with three 30-month option periods, for a total potential value of $999,999,999.00 through December 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor...
The federal contract IDV award SPE2DR25D3003 is a $999,999,999 Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides worldwide pharmaceutical support, including brand-name, generic, and specialty medications, as well as medical supplies and equipment, to various Department of Defense (DoD) customers, the U.S. Coast Guard,...
The federal contract IDV award SPE2DR25D3110 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support global military healthcare programs through December 2036. This IDC serves as the primary contracting vehicle for the DLA...
The federal contract IDV award SPE2DR25D2102 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has an ultimate completion date of December 31, 2036 and supports the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide...

The federal contract IDV award, SPE2DR25D1992, is a single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of December 31, 2036.

The contract's purpose is to establish a Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) to provide worldwide pharmaceutical support, including brand-name, generic, and specialty pharmaceuticals as well as related medical supplies, to various Department of Defense (DoD) customers, the U.S. Coast Guard, and other government agencies. The contract encompasses a wide range of essential medical commodities, such as medications for cardiovascular health, diabetes management, mental health, pain management, infectious disease prevention, and general medical care. The contract will have a 30-month base period with three 30-month option periods, for a total estimated value of $30.3 billion across multiple regional line items. Awards will be made on a regional basis, with at least three different contractors selected, to ensure supply chain resiliency and access to vital pharmaceuticals during contingencies or natural disasters.

Generated 6/6/25, 9:48 AM